Myron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyThere are noFDAapproveddrugs to treathemorrhoidsHemorrhoidsis a $2BmarketWe willhaveexclusivityOur Halo-Lido trial willhave finalpatient byend of 2022Mino-WrapThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We will openupinternationalsites forMino-Lok trialNot manycompaniesthis size with2 late stageassetsMino-Lokpotentialmarket>$1BI/ONTAK'spotentialmarket is>$300mOnly biotechwith 2 Myron'son theleadershipteamWe expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022An actualiMSCupdateWe haveenough cashto go wellinto 2023Insidersinvested$26.5mMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeI won't diluteshareholdersMyron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyThere are noFDAapproveddrugs to treathemorrhoidsHemorrhoidsis a $2BmarketWe willhaveexclusivityOur Halo-Lido trial willhave finalpatient byend of 2022Mino-WrapThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We will openupinternationalsites forMino-Lok trialNot manycompaniesthis size with2 late stageassetsMino-Lokpotentialmarket>$1BI/ONTAK'spotentialmarket is>$300mOnly biotechwith 2 Myron'son theleadershipteamWe expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022An actualiMSCupdateWe haveenough cashto go wellinto 2023Insidersinvested$26.5mMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeI won't diluteshareholders

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Myron Holubiak and I founded a private company in 2013
  2. I'm a shareholder myself
  3. I/ONTAK is our lead asset
  4. We had a phase 2b trial with 100% efficacy
  5. There are no FDA approved drugs to treat hemorrhoids
  6. Hemorrhoids is a $2B market
  7. We will have exclusivity
  8. Our Halo-Lido trial will have final patient by end of 2022
  9. Mino-Wrap
  10. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  11. We will open up international sites for Mino-Lok trial
  12. Not many companies this size with 2 late stage assets
  13. Mino-Lok potential market >$1B
  14. I/ONTAK's potential market is >$300m
  15. Only biotech with 2 Myron's on the leadership team
  16. We expect to finish the Mino-Lok trial this year
  17. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  18. We intend to submit a BLA in 2H 2022
  19. An actual iMSC update
  20. We have enough cash to go well into 2023
  21. Insiders invested $26.5m
  22. Mino-Lok is our lead asset
  23. I/ONTAK was the best deal I ever made
  24. I won't dilute shareholders